---
layout: post
title: "Blood Products Advisory Committee; Notice of Meeting"
date: 2026-02-05 19:08:32 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-02873
original_published: 2020-02-13 00:00:00 +0000
significance: 8.00
---

# Blood Products Advisory Committee; Notice of Meeting

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** February 13, 2020 00:00 UTC
**Document Number:** 2020-02873

## Summary

The Food and Drug Administration (FDA or Agency) announces a forthcoming public advisory committee meeting of the Blood Products Advisory Committee (BPAC). The general function of the committee is to provide advice and recommendations to the Agency on FDA's regulatory issues related to blood and products derived from blood. Matters considered at the meeting will include current strategies to reduce the risk of Zika virus (ZIKV) transmission by blood and blood components, an update on the Transfusion Transmissible Infections Monitoring System (TTIMS), and testing blood donations for hepatitis B surface antigen. The meeting will be open to the public.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/02/13/2020-02873/blood-products-advisory-committee-notice-of-meeting)
- API: https://www.federalregister.gov/api/v1/documents/2020-02873

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
